PATIENTS WITH END-STAGE RENAL DISEASE ADMITTED TO THE INTENSIVE CARE UNIT: SYSTEMATIC REVIEW
DOI:
https://doi.org/10.53555/nnmhs.v9i6.1736Keywords:
Chronic kidney disease, End-stage renal disease, Intensive care unitAbstract
Background: The prevalence and incidence of Chronic Kidney Disease (CKD), especially End-Stage Renal Disease (ESRD), are rising globally, primarily due to aging populations, hypertension, diabetes, and obesity. The prevalence of chronic kidney disease (CKD) in critically ill patients is incompletely documented.
Aim: This study aims to determine the frequency of critical care unit visits among individuals with end-stage renal disease.
Methods: This study demonstrated compliance with all requirements of the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 standards through self-comparison. The experts ensured the study's maximum contemporaneity. The search strategy involved examining publications published from 2013 to 2023. This was accomplished using various online reference databases, including Pubmed and SagePub. Only completed papers and publications were considered, while incomplete pieces and previously published works were excluded.
Result: 1,662 and 1,212 articles were retrieved from PubMed and SagePub, respectively. In 2013, we collated 16 papers, including 11 from PubMed and 5 from SagePub, 4 of which met the research criteria.
Conclusion: ICU patients frequently exhibit advanced kidney disease and elevated mortality rates.
References
1. Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019 Jan;62(1):3–16.
2. Wong E. Chronic Kidney Disease. Lancet. 2012;379(8911):80–165.
3. KDIGO CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. New York; 2013.
4. Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019 Apr;23(4):437–47.
5. Wyld MLR, Morton RL, Aouad L, Magliano D, Polkinghorne KR, Chadban S. The impact of comorbid chronic kidney disease and diabetes on health-related quality-of-life: a 12-year community cohort study. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2021 May;36(6):1048–56.
6. Inaguma D, Imai E, Takeuchi A, Ohashi Y, Watanabe T, Nitta K, et al. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study. Clin Exp Nephrol. 2017 Jun;21(3):446–56.
7. Lees JS, Welsh CE, Celis-Morales CA, Mackay D, Lewsey J, Gray SR, et al. Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nat Med. 2019 Nov;25(11):1753–60.
8. Schnaper HW. Remnant nephron physiology and the progression of chronic kidney disease. Pediatr Nephrol. 2014 Feb;29(2):193–202.
9. Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol. 2007;18(10):2644–8.
10. Adhikari NKJ, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet. 2010;376(9749):1339–46.
11. Vincent J-L, Marshall JC, Ñamendys-Silva SA, François B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med [Internet]. 2014;2(5):380–6. Available from: https://www.sciencedirect.com/science/article/pii/S221326001470061X
12. Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med [Internet]. 2015;41(8):1411–23. Available from: https://doi.org/10.1007/s00134-015-3934-7
13. Kim MH, Koh SO, Kim EJ, Cho JS, Na S-W. Incidence and outcome of contrast-associated acute kidney injury assessed with Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) criteria in critically ill patients of medical and surgical intensive care units: a retrospective study. BMC Anesthesiol. 2015;15:23.
14. Srisawat N, Sileanu FE, Murugan R, Bellomod R, Calzavacca P, Cartin-Ceba R, et al. Variation in risk and mortality of acute kidney injury in critically ill patients: a multicenter study. Am J Nephrol. 2015;41(1):81–8.
15. Neyra JA, Mescia F, Li X, Adams-Huet B, Yessayan L, Yee J, et al. Impact of Acute Kidney Injury and CKD on Adverse Outcomes in Critically Ill Septic Patients. Kidney Int Reports [Internet]. 2018;3(6):1344–53. Available from: https://www.sciencedirect.com/science/article/pii/S2468024918301621
16. Gammelager H, Christiansen CF, Johansen MB, Tønnesen E, Jespersen B, Sørensen HT. Five-year risk of end-stage renal disease among intensive care patients surviving dialysis-requiring acute kidney injury: a nationwide cohort study. Crit care. 2013;17(4):1–8.
17. Iwagami M, Yasunaga H, Matsui H, Horiguchi H, Fushimi K, Noiri E, et al. Impact of end?stage renal disease on hospital outcomes among patients admitted to intensive care units: a retrospective matched?pair cohort study. Nephrology. 2017;22(8):617–23.
18. Arulkumaran N, Annear NMP, Singer M. Patients with end-stage renal disease admitted to the intensive care unit: systematic review. Br J Anaesth. 2013 Jan;110(1):13–20.
19. Jeganathan N, Ahuja N, Yau S, Otu D, Stein B, Balk RA. Impact of end-stage renal disease and acute kidney injury on ICU outcomes in patients with sepsis. J Intensive Care Med. 2017;32(7):444–50.
20. Chan M, Ostermann M. Outcomes of chronic hemodialysis patients in the intensive care unit. Crit Care Res Pract. 2013;2013.
21. Fortrie G, de Geus HRH, Betjes MGH. The aftermath of acute kidney injury: a narrative review of long-term mortality and renal function. Crit Care. 2019;23(1):1–11.
22. Seeley EJ. Updates in the management of acute lung injury: a focus on the overlap between AKI and ARDS. Adv Chronic Kidney Dis. 2013;20(1):14–20.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Journal of Advance Research in Medical & Health Science (ISSN: 2208-2425)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
